Literature DB >> 12792918

The pattern of CD10 expression in selected pathologic entities of the prostate gland.

Sherif Tawfic1, Gloria A Niehans, J Carlos Manivel.   

Abstract

There is increasing evidence that neuropeptides, including bombesin, may influence growth, angiogenesis, invasiveness, and metastasis in prostate cancer. One of the molecules tightly involved in the regulation of neuropeptide activity is the integral membrane glycoprotein CD10, or neutral endopeptidase 24.11. The pattern of CD10 expression in hyperplastic and neoplastic conditions of the prostate gland has not been previously described. Immunohistochemical staining for CD10 and high-molecular-weight cytokeratin was performed on 92 cases of paraffin-embedded tissue from needle-core biopsy specimens and prostatectomy specimens. Normal and hyperplastic acini showed strong and distinct membrane (apical and intercellular) and cytoplasmic CD10 expression in basal and secretory cells. In contrast, no intercellular membrane or cytoplasmic staining of secretory cells was seen in any cases of adenocarcinoma with Gleason patterns 2 or 3. A subset of high-Gleason grade adenocarcinoma (patterns 4 and 5) displayed CD10 expression in the secretory cells; those cases shared a distinct morphological pattern. Prostatic intraepithelial neoplasia (PIN) showed consistent absence of intercellular membrane and cytoplasmic CD10 expression in the secretory cells, with preserved expression in basal cells. Interestingly, the basal cells in basal cell hyperplasia lacked CD10 expression, and no expression was noted in the secretory cells in all cases examined. Atrophic acini and those associated with acute and chronic inflammation retained CD10 expression. In conclusion, a consistent differential pattern of CD10 expression was seen in basal cell hyperplasia, PIN, and adenocarcinoma, suggesting a role for CD10 in the pathobiology of the prostate gland.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792918     DOI: 10.1016/s0046-8177(03)00077-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  Heterotopic Prostate at Autopsy- An Unusual Mass at the Dome of the Urinary Bladder.

Authors:  Shital Munde; Gwendolyn Fernandes; Priyanka Phadnis
Journal:  J Clin Diagn Res       Date:  2017-09-01

2.  CD10 expression in epithelial and stromal cells of non-small cell lung carcinoma (NSCLC): a clinic and pathologic correlation.

Authors:  Duygu Gürel; Aydanur Kargı; Ilgın Karaman; Ahmet Onen; Mehtat Unlü
Journal:  Pathol Oncol Res       Date:  2011-06-18       Impact factor: 3.201

3.  Carcinosarcoma of the prostate: two cases with distinctive morphologic and immunohistochemical findings.

Authors:  Noelia Perez; Mireia Castillo; Yolanda Santos; David Truan; Rafael Gutierrez; Agustin Franco; Antonio Palacin; Josep Antoni Bombi; Elias Campo; Pedro L Fernandez
Journal:  Virchows Arch       Date:  2005-04-09       Impact factor: 4.064

4.  Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile.

Authors:  Alvin Y Liu; Martine P Roudier; Lawrence D True
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays.

Authors:  Yan Li; Sheng-Ce Tao; G Steven Bova; Alvin Y Liu; Daniel W Chan; Heng Zhu; Hui Zhang
Journal:  Anal Chem       Date:  2011-10-26       Impact factor: 6.986

6.  Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.

Authors:  Michael C Risk; Beatrice S Knudsen; Ilsa Coleman; Ruth F Dumpit; Alan R Kristal; Nolwenn LeMeur; Robert C Gentleman; Lawrence D True; Peter S Nelson; Daniel W Lin
Journal:  Clin Cancer Res       Date:  2010-10-08       Impact factor: 12.531

7.  CD10 expression by fusiform stromal cells in nasopharyngeal carcinoma correlates with tumor progression.

Authors:  Hend Braham; Mounir Trimeche; Sonia Ziadi; Sarra Mestiri; Moncef Mokni; Khaled Amara; Mohamed Hachana; Badreddine Sriha; Sadok Korbi
Journal:  Virchows Arch       Date:  2006-05-04       Impact factor: 4.064

8.  Differential expression of CD10 in prostate cancer and its clinical implication.

Authors:  Marc A Dall'Era; Lawrence D True; Andrew F Siegel; Michael P Porter; Tracy M Sherertz; Alvin Y Liu
Journal:  BMC Urol       Date:  2007-03-02       Impact factor: 2.264

9.  CD10 expression in urothelial carcinoma of the bladder.

Authors:  Burak Bahadir; Kemal Behzatoglu; Sibel Bektas; Erol R Bozkurt; Sukru O Ozdamar
Journal:  Diagn Pathol       Date:  2009-11-16       Impact factor: 2.644

10.  Ectopic prostate tissue at the bladder dome presenting as a bladder tumor.

Authors:  Jae Heon Kim; Yoon Mi Jeen; Yun Seob Song
Journal:  World J Mens Health       Date:  2013-08-31       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.